Prognostic significance of annexin VII expression in glioblastomas multiforme in humans

Kuo Sheng Hung, Shen Long Howng

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Object. Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor in adults. It is nearly uniformly fatal, with a median survival time of approximately 1 year, despite modern treatment modalities. Nevertheless, a range of survival times exists around this median. Efforts to understand why some patients live longer or shorter than the average may provide insight into the biology of the:;e neoplasms. The annexin VII (ANX7) gene is located on the human chromosome 10q21, a site long hypothesized to hart or tumor suppressor genes associated with prostate and other cancers. To test whether ANX7 expression might be a predictor for GBMs, we examined ANX7 expression, p53 accumulation, and the MIB-1 labeling index in a retrospective series of 99 GBMs. Methods. In all 99 cases, the patient's age, Karnofsky Performance Scale (KPS) score before surgery, extent of surgery, tumor location, and immunohistochemical features were analyzed using univariate and multivariate analyses to identify whether any significance exists among ANX7 expression, p53 accumulation, the MIB-1 labeling index, and survival time. Kaplan-Meier analyses demonstrated that a higher KPS score before surgery (<0.0001), total tumor excision (p = 0.0072), young patient age (p = 0.03), and ANX7 expression (p = 0.0006) correlated with longer survival. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001), independent of all other variables. In addition, ANX7 expression correlated with higher MIB-1 immunostaining, but did not correlate with p53 accumulation. Moreover, a significant positive correlation was observed between p53 and MIB-1 staining. Conclusions. These findings indicate that a higher KPS score before surgery, total tumor excision, young patient age, and ANX7 expression correlate with longer survival in patients with GBMs. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001) and was independent of all other variables.

Original languageEnglish
Pages (from-to)886-892
Number of pages7
JournalJournal of Neurosurgery
Volume99
Issue number5
Publication statusPublished - Nov 2003
Externally publishedYes

Fingerprint

Annexin A7
Glioblastoma
Karnofsky Performance Status
Survival
Neoplasms
Regression Analysis
Kaplan-Meier Estimate
Human Chromosomes
Tumor Suppressor Genes
Brain Neoplasms
Prostatic Neoplasms
Multivariate Analysis
Staining and Labeling
Genes

Keywords

  • Glioblastoma multiforme
  • Prognosis
  • Proliferation marker
  • Tumor suppressor protein

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Prognostic significance of annexin VII expression in glioblastomas multiforme in humans. / Hung, Kuo Sheng; Howng, Shen Long.

In: Journal of Neurosurgery, Vol. 99, No. 5, 11.2003, p. 886-892.

Research output: Contribution to journalArticle

@article{db8739afe3a942619cc53480a4eb9b36,
title = "Prognostic significance of annexin VII expression in glioblastomas multiforme in humans",
abstract = "Object. Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor in adults. It is nearly uniformly fatal, with a median survival time of approximately 1 year, despite modern treatment modalities. Nevertheless, a range of survival times exists around this median. Efforts to understand why some patients live longer or shorter than the average may provide insight into the biology of the:;e neoplasms. The annexin VII (ANX7) gene is located on the human chromosome 10q21, a site long hypothesized to hart or tumor suppressor genes associated with prostate and other cancers. To test whether ANX7 expression might be a predictor for GBMs, we examined ANX7 expression, p53 accumulation, and the MIB-1 labeling index in a retrospective series of 99 GBMs. Methods. In all 99 cases, the patient's age, Karnofsky Performance Scale (KPS) score before surgery, extent of surgery, tumor location, and immunohistochemical features were analyzed using univariate and multivariate analyses to identify whether any significance exists among ANX7 expression, p53 accumulation, the MIB-1 labeling index, and survival time. Kaplan-Meier analyses demonstrated that a higher KPS score before surgery (<0.0001), total tumor excision (p = 0.0072), young patient age (p = 0.03), and ANX7 expression (p = 0.0006) correlated with longer survival. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001), independent of all other variables. In addition, ANX7 expression correlated with higher MIB-1 immunostaining, but did not correlate with p53 accumulation. Moreover, a significant positive correlation was observed between p53 and MIB-1 staining. Conclusions. These findings indicate that a higher KPS score before surgery, total tumor excision, young patient age, and ANX7 expression correlate with longer survival in patients with GBMs. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001) and was independent of all other variables.",
keywords = "Glioblastoma multiforme, Prognosis, Proliferation marker, Tumor suppressor protein",
author = "Hung, {Kuo Sheng} and Howng, {Shen Long}",
year = "2003",
month = "11",
language = "English",
volume = "99",
pages = "886--892",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Prognostic significance of annexin VII expression in glioblastomas multiforme in humans

AU - Hung, Kuo Sheng

AU - Howng, Shen Long

PY - 2003/11

Y1 - 2003/11

N2 - Object. Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor in adults. It is nearly uniformly fatal, with a median survival time of approximately 1 year, despite modern treatment modalities. Nevertheless, a range of survival times exists around this median. Efforts to understand why some patients live longer or shorter than the average may provide insight into the biology of the:;e neoplasms. The annexin VII (ANX7) gene is located on the human chromosome 10q21, a site long hypothesized to hart or tumor suppressor genes associated with prostate and other cancers. To test whether ANX7 expression might be a predictor for GBMs, we examined ANX7 expression, p53 accumulation, and the MIB-1 labeling index in a retrospective series of 99 GBMs. Methods. In all 99 cases, the patient's age, Karnofsky Performance Scale (KPS) score before surgery, extent of surgery, tumor location, and immunohistochemical features were analyzed using univariate and multivariate analyses to identify whether any significance exists among ANX7 expression, p53 accumulation, the MIB-1 labeling index, and survival time. Kaplan-Meier analyses demonstrated that a higher KPS score before surgery (<0.0001), total tumor excision (p = 0.0072), young patient age (p = 0.03), and ANX7 expression (p = 0.0006) correlated with longer survival. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001), independent of all other variables. In addition, ANX7 expression correlated with higher MIB-1 immunostaining, but did not correlate with p53 accumulation. Moreover, a significant positive correlation was observed between p53 and MIB-1 staining. Conclusions. These findings indicate that a higher KPS score before surgery, total tumor excision, young patient age, and ANX7 expression correlate with longer survival in patients with GBMs. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001) and was independent of all other variables.

AB - Object. Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor in adults. It is nearly uniformly fatal, with a median survival time of approximately 1 year, despite modern treatment modalities. Nevertheless, a range of survival times exists around this median. Efforts to understand why some patients live longer or shorter than the average may provide insight into the biology of the:;e neoplasms. The annexin VII (ANX7) gene is located on the human chromosome 10q21, a site long hypothesized to hart or tumor suppressor genes associated with prostate and other cancers. To test whether ANX7 expression might be a predictor for GBMs, we examined ANX7 expression, p53 accumulation, and the MIB-1 labeling index in a retrospective series of 99 GBMs. Methods. In all 99 cases, the patient's age, Karnofsky Performance Scale (KPS) score before surgery, extent of surgery, tumor location, and immunohistochemical features were analyzed using univariate and multivariate analyses to identify whether any significance exists among ANX7 expression, p53 accumulation, the MIB-1 labeling index, and survival time. Kaplan-Meier analyses demonstrated that a higher KPS score before surgery (<0.0001), total tumor excision (p = 0.0072), young patient age (p = 0.03), and ANX7 expression (p = 0.0006) correlated with longer survival. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001), independent of all other variables. In addition, ANX7 expression correlated with higher MIB-1 immunostaining, but did not correlate with p53 accumulation. Moreover, a significant positive correlation was observed between p53 and MIB-1 staining. Conclusions. These findings indicate that a higher KPS score before surgery, total tumor excision, young patient age, and ANX7 expression correlate with longer survival in patients with GBMs. Multivariate Cox regression analyses demonstrated that ANX7 expression was the strongest predictor of outcome (p <0.0001) and was independent of all other variables.

KW - Glioblastoma multiforme

KW - Prognosis

KW - Proliferation marker

KW - Tumor suppressor protein

UR - http://www.scopus.com/inward/record.url?scp=0142244766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142244766&partnerID=8YFLogxK

M3 - Article

C2 - 14609169

AN - SCOPUS:0142244766

VL - 99

SP - 886

EP - 892

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 5

ER -